Information-Rich Solutions to Transform Cell Therapy Research and Discovery
The emerging field of cell therapy has the potential to deliver breakthrough treatments for a range of diseases including cancer. Scientists developing adoptive cell and other novel cell therapies require advanced tools for monitoring cells at every workflow step, from cell isolation, to manufacturing and packaging. Traditional microscopy or flow-based systems are limited with respect to scalability, ease of operation, sample conservation, and reporting on temporal effects. The Sartorius cell analysis platforms offer unique, high-capacity solutions for characterizing immune phenotype and function at unprecedented speed, depth and scale, throughout the cell therapy research and development process.
Sartorius cell analysis platforms provide information-rich solutions for tracking complex biological processes. Our innovative technologies generate deeper and more relevant data on immune cell phenotype, activation, and function, using less of your precious samples. Unlike other approaches that require multiple assays or time points, our technologies reduce variability by delivering more data per time point, or multiple time points, in the same context, under the same conditions. Using our comprehensive analysis and visualization capabilities you will have access to actionable results, faster.
We offer unique solutions to address critical applications in the cell therapy workflow.
How We Accelerate Your Discovery
Speed, Depth, and Scale
- Our instruments give information-rich data, with faster and higher throughput sample processing. Get actionable results, faster with our comprehensive data and analysis tools.
Robust and Reproducible Data
- Get quantitative, reproducible, and physiologically-relevant data using our cell analysis platforms.
- Reduce your sample volume requirements and perform non-perturbing experiments with our patented sampling technology.
- Our instruments allow data collection over time, showing donor-to-donor variability and single-donor heterogeneity.
NEW WHITE PAPER
Advancing next generation therapeutics with real-time, live-cell analysis
Unprecedented advances in medicine are delivering remarkable results for some patients. Recent approvals of CAR T therapies and new approaches in regenerative medicine, for example, exemplify the progress being made. Much work remains, however, to extend the benefits of these game-changing treatment modalities to a larger patient population...
CAR T-cell Therapy and Bispecific Antibodies: Frontiers in Cancer Immunotherapy
Register now to watch a panel of experts discuss the design, development, and success of CAR T-cell therapy and bispecific antibodies and the potential these therapeutics hold in the fight against various tumor types.
Choose your application
Cell Therapy Resources
Enjoy these resources to help you find information-rich solutions to transform cell therapy research and discovery.